Cefuroxime is a prescription antibiotic belonging to the cephalosporin class. The active ingredient in cefuroxime tablets is cefuroxime axetil, a pro-drug that is rapidly converted in the gastrointestinal tract to the active molecule cefuroxime.
Cefuroxime axetil is absorbed from the gut and hydrolysed to cefuroxime, the pharmacologically active form. Cefuroxime then inhibits bacterial cell-wall synthesis by binding to penicillin-binding proteins (PBPs) located on the inner surface of the bacterial cell membrane. This binding blocks the final transpeptidation step that cross-links peptidoglycan strands, weakening the wall and causing bacterial lysis.
Because cefuroxime is bactericidal, it actively kills susceptible bacteria rather than merely inhibiting their growth.
Cefuroxime is approved in Hong Kong for a range of bacterial infections, including:
The choice of dosage (250 mg vs. 500 mg) depends on infection severity, site, and the susceptibility pattern of the causative bacteria.
Cefuroxime is appropriate for adult patients who require treatment for the infections listed above and have no known hypersensitivity to cephalosporins or penicillins. Renal function should be assessed before initiating therapy, especially in patients with chronic kidney disease.
If any of these conditions apply, a healthcare provider should evaluate the risk-benefit profile before prescribing.
These events are generally self-limiting and do not require discontinuation unless they become severe.
Any sign of a severe reaction should prompt immediate medical attention.
Patients should always disclose all concurrent medications, supplements, and herbal products to their prescriber.
Standard adult dosing:
Mild to moderate infections: 250 mg orally every 12 hours.
More serious infections (e.g., CAP, complicated UTIs): 500 mg orally every 12 hours.
Renal adjustment: Reduce dose to 250 mg once daily if creatinine clearance is <30 mL/min; avoid use if on dialysis without specialist guidance.
Administration tips:
Swallow tablets whole with a full glass of water.
Take with food to enhance absorption, especially for the lower dose.
Do not crush or chew extended-release formulations (if any are prescribed).
Missed dose: Take the missed dose as soon as remembered unless the next scheduled dose is within 2 hours; in that case, skip the missed dose and resume the regular schedule. Do not double the dose.
Overdose: Symptoms may include nausea, vomiting, abdominal pain, and possible seizures. Seek emergency care; supportive treatment and gastric lavage are standard measures.
Discontinuation: Complete the full prescribed course even if symptoms resolve early. No tapering is required because cefuroxime does not cause dependence.
This article provides educational information about cefuroxime and is not a substitute for professional medical advice. Treatment decisions, including the use of antibiotics for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes only and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Yes, cefuroxime can be carried in its original packaging with a copy of the prescription. In Hong Kong, travelers should retain the prescription and a pharmacist-issued medication record to satisfy customs or airline security checks.
Taking cefuroxime with meals improves its oral bioavailability, especially for the 250 mg strength. It is advisable to consume the medication together with food to ensure optimal plasma concentrations.
Cefuroxime is not a performance-enhancing substance and is not screened for in standard sports anti-doping tests. However, athletes should inform anti-doping officials of any prescribed medication.
Authentic tablets are imprinted with the dosage strength (e.g., “250” or “500”) and the manufacturer’s logo. The color, shape, and imprint should match the description on the packaging insert. Any discrepancy should be reported to a pharmacist.
Cefuroxime axetil is an oral pro-drug formulated for tablet use, whereas cefuroxime sodium is the injectable form used for intravenous or intramuscular therapy. Both convert to the same active molecule after administration.
Cefuroxime does not reliably cover methicillin-resistant Staphylococcus aureus (MRSA). For suspected MRSA infections, alternative antibiotics with proven activity should be considered.
Empirical treatment may be appropriate for uncomplicated UTIs, but a urine culture is recommended to confirm pathogen susceptibility and to avoid unnecessary antibiotic exposure.
Take the missed dose as soon as you remember, unless it is within two hours of the next scheduled dose; in that case, skip the missed dose and continue with the regular dosing interval. Do not double the dose.
Tablets remain stable until the printed expiration date, provided they are kept in a dry place at room temperature and the bottle is tightly closed. Do not use tablets past their expiration date.
Second-generation cephalosporins, like cefuroxime, have an expanded spectrum against Gram-negative bacteria compared with first-generation agents, while retaining activity against many Gram-positive organisms. This broader coverage makes them useful for respiratory and urinary infections.
